STEAP2 and prostate carcinoma: STEAP2 is highly expressed at all stages of prostate cancer and is androgen independent, a characteristic that is key in managing androgen-dependent and independent/advanced prostate cancer [(Gomes et al., 2012), (Hubert et al., 1999)].